-
Syros Closes $90.5 Million Strategic Financing
Post on 12/8/20
-
Peak Physical Therapy & Sports Performance Promotes Samantha Meade to Lead Physical Therapy Aide for the Company
Post on 12/8/20
-
Trinity Life Sciences Acquires BluePrint Research Group
Post on 12/8/20
-
Pear Therapeutics Closes $80M Series D Financing
Post on 12/8/20
-
Vigil Neuroscience Launches $50 Million Series A
Post on 12/8/20
-
Bristol-Myers Squibb Contingent Value Rights: Final Inspection Is Happening
Post on 12/8/20
-
Could Moderna Be a Millionaire-Maker Stock?
Post on 12/8/20
-
Canada Doubles Its Commitment to Moderna's Coronavirus Vaccine to 40 Million Doses
Post on 12/8/20
-
Syndax Announces Proposed Public Offering of Common Stock
Post on 12/7/20
-
CVS Health Corporation Cash Tender Offers for Certain Outstanding Notes
Post on 12/7/20
-
Repligen Corporation Proposes Public Offering of Shares of Common Stock
Post on 12/7/20
-
Is Moderna's Stock Price Ridiculously Expensive Right Now?
Post on 12/7/20
-
Intellia Therapeutics Closes $201M Public Offering of Common Stock
Post on 12/6/20
-
Cogent Biosciences Closes Upsized Public Offering of Common Stock
Post on 12/6/20
-
Foghorn Therapeutics Announces Third Quarter 2020 Financial Results and Provides Corporate Update
Post on 12/4/20
-
Merck Just Sold Off Its Moderna Shares for a Huge Gain. Should You?
Post on 12/4/20
-
Is Vertex Pharmaceuticals Stock a Buy?
Post on 12/4/20
-
Could Moderna Be a Millionaire-Maker Stock?
Post on 12/4/20
-
Should Investors Buy Moderna Stock for Its Coronavirus Vaccine?
Post on 12/4/20
-
Sigilon Therapeutics Prices Upsized Initial Public Offering
Post on 12/3/20
-
Lantheus Holdings Sell Its Puerto Rico Radiopharmacy and PET Manufacturing Facility
Post on 12/3/20
-
BeiGene Prices of Public Offering
Post on 12/2/20
-
Infinity Pharmaceutical Reaching Vital New Staging Posts
Post on 12/2/20
-
IPO Update: Sigilon Therapeutics Aims For $101 Million IPO
Post on 12/2/20
-
Intellia Therapeutics Prices of Public Offering of Common Stock
Post on 12/2/20
Boston
